Median effect analysis of efficacy versus adverse effects of immunosuppressants.

Median effect analysis of efficacy versus adverse effects of immunosuppressants.

Item
http://www.wikidata.org/entity/Q33338134
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsImmunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolismAlterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.FTY720: A new kid on the block for transplant immunosuppression.Clinical application of sirolimus in renal transplantation: an update.A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.Sirolimus: its role in nephrology.Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients.Tumor growth effects of rapamycin on human biliary tract cancer cells.An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.Effect of sirolimus withdrawal in patients with deteriorating renal function.Janus kinase 3: a novel target for selective transplant immunosupression.Analysis of exposure-response relationship in everolimus-cyclosporine combination regimen.Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
P2860

Median effect analysis of efficacy versus adverse effects of immunosuppressants.

Item
http://www.wikidata.org/entity/Q33338134
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@ast
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@en
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@nl
type
label
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@ast
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@en
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@nl
prefLabel
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@ast
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@en
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921